{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:24:22Z","timestamp":1780547062709,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":3209,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.jmoldx.2010.11.016","type":"journal-article","created":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T07:47:33Z","timestamp":1298706453000},"page":"160-166","source":"Crossref","is-referenced-by-count":33,"title":["Clinical Experience with the Cervista HPV HR Assay"],"prefix":"10.1016","volume":"13","author":[{"given":"Kenneth E.","family":"Youens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Hosler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J.","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Patrick","family":"Jenevein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2010.11.016_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/314111a0","article-title":"Structure and transcription of human papillomavirus sequences in cervical carcinoma cells","volume":"314","author":"Schwarz","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1470-2045(05)70086-3","article-title":"Carcinogenicity of human papillomaviruses","volume":"6","author":"Cogliano","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2006.07.031","article-title":"Clinical utility of HPV genotyping","volume":"103","author":"Meijer","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib5","first-page":"147","article-title":"Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology","volume":"80","author":"Apgar","year":"2009","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3322\/caac.20063","article-title":"Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening","volume":"60","author":"Smith","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0002-9378(03)00418-6","article-title":"Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance","volume":"188","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jnci\/95.1.46","article-title":"Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis","volume":"95","author":"Sherman","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 Consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib10","first-page":"1","article-title":"Clinical validation of the Cervista HPV HR and 16\/18 genotyping tests for use in women with ASC-US cytology","volume":"17","author":"Einstein","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib11","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1128\/JCM.01824-07","article-title":"Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the Digene HPV Hybrid Capture 2 assay for detection of high-risk HPV DNA","volume":"46","author":"Ginocchio","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib12","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"issue":"suppl","key":"10.1016\/j.jmoldx.2010.11.016_bib13","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S1386-6532(02)00187-7","article-title":"Hybrid Capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail","volume":"25","author":"Poljak","year":"2002","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1309\/4DXEAFG2JXYF34N3","article-title":"A comparison of two methods to determine the presence of high-risk HPV cervical infections","volume":"130","author":"Johnson","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib15","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1128\/JCM.01833-07","article-title":"Detection of high-risk papillomavirus DNA with commercial Invadertechnology\u2013based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media","volume":"45","author":"Schutzbank","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/JCM.01424-07","article-title":"Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay","volume":"46","author":"Wong","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e3181996ffa","article-title":"Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting","volume":"13","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-148-7-200804010-00004","article-title":"Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003\u20132005","volume":"148","author":"Datta","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib19","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.22241","article-title":"Variations in the age-specific curves of human papillomavirus prevalence in women worldwide","volume":"119","author":"Franceschi","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/LGT.0b013e318186d76a","article-title":"Prevalence of high-risk human papillomavirus in an inner-city population with atypical squamous cells of undetermined significance","volume":"13","author":"Allen","year":"2009","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib22","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1309\/AJCPAZV88VIFZSFD","article-title":"High-risk HPV testing in women 30 years or older with negative Papanicolaou tests: initial clinical experience with 18-month follow-up","volume":"33","author":"Thrall","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/cncr.21664","article-title":"Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes","volume":"106","author":"Evans","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2","article-title":"Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types","volume":"87","author":"Jacobs","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib25","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/sj.bjc.6604324","article-title":"Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial","volume":"98","author":"Sargent","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib26","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"85","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1309\/AJCPRI8XPQUEAA3K","article-title":"Patient safety and the next generation of HPV DNA tests","volume":"134","author":"Kinney","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib28","unstructured":"Wu R, Du H, Belinson S, Yang B, Qu X, Wang C, Wu R, Wang G, Yang G, Belinson JL: P-191: The Shenzhen Cervical Cancer Screening Trial II (SHENCCAST II). Presented at the 26th International Papillomavirus Conference; July 3\u20138, 2010; Montreal, QC, Canada"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib29","doi-asserted-by":"crossref","first-page":"26.e1","DOI":"10.1016\/j.ajog.2007.11.051","article-title":"Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States","volume":"199","author":"Baseman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/PDM.0b013e31805c99ae","article-title":"Resolution of equivocal results with the Hybrid Capture II High-Risk HPV DNA Test: a cytologic\/ histologic review of 191 cases","volume":"16","author":"Knoepp","year":"2007","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib31","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cncr.22285","article-title":"Human papillomavirus testing using Hybrid Capture II with SurePath collection: initial evaluation and longitudinal data provide clinical validation for this method","volume":"108","author":"Ko","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2010.11.016_bib32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/cncy.20043","article-title":"Hybrid cCapture 2 human papillomavirus DNA testing for women with atypical squamous cells of undetermined significance: Papanicolaou results in SurePath and ThinPrep specimens","volume":"117","author":"Siddiqi","year":"2009","journal-title":"Cancer Cytopathol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152515781000053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152515781000053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T07:37:22Z","timestamp":1576222642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152515781000053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S152515781000053X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2010.11.016","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}